Oral cancer differential diagnosis: Difference between revisions
Line 437: | Line 437: | ||
|Non-Hodgkin lymphoma | |Non-Hodgkin lymphoma | ||
| | | | ||
|Second most com- | |||
mon cancer of the oral cavity. | |||
| | | | ||
* There is no known etiology in most patients. | |||
* Underlying immunodeficiency state (e.g. HIV Infection) | |||
* Strong association with EBV | |||
| | | | ||
| | | | ||
* Palate, | |||
* Tongue | |||
* Floor of mouth | |||
* Gingiva | |||
* Buccal mucosa | |||
* Lips | |||
* Palatine tonsils | |||
* Lingual tonsils or | |||
* Oropharynx | |||
|NHL of the lip presents with: | |||
* Ulcer | |||
* Swelling, | |||
* Discoloration | |||
* Pain | |||
* Paraesthesia | |||
* Anaesthesia, or | |||
* Loose teeth | |||
| | | | ||
Biopsy shows: | |||
* Large cells with predominantly round nuclei and membrane-bound nucleoli, consistent with centroblastic morphology. | |||
* Predominantly medium-sized cells with abundant pale cytoplasm. | |||
* Large cells with round or multilobated nuclei | |||
|- | |- | ||
|Extramedullary plasmacytoma | |Extramedullary plasmacytoma | ||
| | |9734/3 | ||
| | | | ||
| | | | ||
Line 454: | Line 484: | ||
|- | |- | ||
|Langerhans cell histiocytosis | |Langerhans cell histiocytosis | ||
|9751/1 | |||
| | | | ||
|Associated with: | |||
* Eosinophilic granulomas | |||
* Multifocal multisystem disease | |||
| | | | ||
| | | | ||
| | * Jaw bone | ||
| | * Intraoral soft tissues | ||
* Gingiva | |||
* Palate | |||
* Floor of mouth | |||
* Buccal mucosa | |||
and | |||
* Tonsil | |||
|Common oral symptoms | |||
include: | |||
* Swelling | |||
* Pain | |||
* Gingivitis | |||
* Loose teeth and | |||
* Ulceration | |||
|Biopsy shows ovoid Langerhans cells | |||
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |||
|- | |- | ||
|Hodgkin lymphoma | |Hodgkin lymphoma | ||
| | | | ||
| | | | ||
|Strongly associated with Epstein- Barr Virus | |||
| | | | ||
| | | | ||
| | * Waldeyer ring, particularly the pala-tine tonsil | ||
* Oropharynx | |||
* Alveolar crest of mandible | |||
* Maxillary gingiva | |||
|Most patients present with localized disease (stage I/II), with | |||
* Chronic tonsillitis or tonsillar enlargement with or without enlarged cervical lymph nodes | |||
| | | | ||
|- | |- | ||
|Extramedullary myeloid | |Extramedullary myeloid | ||
sarcoma | sarcoma | ||
|9930/3 | |||
| | | | ||
|History of acute myeloid leukaemia, | |||
predominantly in the monocytic or | |||
myelomonocytic subtypes | |||
| | | | ||
| | | | ||
* Palate | |||
| | * Gingiva | ||
| | |Isolated tumor-forming intraoral mass | ||
|Biopsy shows an Indian-file pattern of infiltration | |||
|- | |- | ||
|Follicular dendritic cell | |Follicular dendritic cell | ||
sarcoma / tumour | sarcoma / tumour | ||
|9758/3 | |||
| | | | ||
* Tumor of adulthood | |||
* Affects wide age range | |||
|History of underlying hya-line-vascular Castleman disease | |||
| | | | ||
| | | | ||
| | * Tonsil | ||
| | * Palate or | ||
* Oropharynx. | |||
|The patients usually | |||
present with a painless mass | |||
|Biopsy usually exhibits | |||
borders and comprises: | |||
* Fascicles | |||
* Whorls | |||
* Nodules, | |||
* Storiform arrays or | |||
* Diffuse sheets of spindly to ovoid tumour cells sprinkled with small lymphocytes | |||
|- | |- | ||
|Mucosal malignant melanoma | |Mucosal malignant melanoma | ||
| | | | ||
|8720/3 | |||
| | | | ||
* 0.5% of oral malignancies | |||
* Incidence 0.02 per 100,000 | |||
|No known etiological factors associated with oral melanoma | |||
| | | | ||
|80% arise: | |||
* Palate | |||
* Maxillary alveolus or gingivae | |||
* Mandibular | |||
gingivae | |||
Others: | |||
* Buccal mucosa | |||
* Floor of mouth | |||
* Tongue | |||
| | | | ||
* Asymmetric with irregular outlines | |||
* Macular pigmentation | |||
* Nodular growth | |||
* Ulceration | |||
* Melanosis | |||
| | | | ||
* Biopsy: | |||
* S100 positive | |||
* Negative for cytokeratins | |||
* More specific markers include: | |||
* HMB45, | |||
* Melan-A or anti-tyrosinase | |||
|} | |} | ||
Revision as of 19:15, 5 February 2018
Oral cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Oral cancer differential diagnosis |
Risk calculators and risk factors for Oral cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
There are different types of cancers of the oral cavity and oropharynx. It is important that they are differentiated from one another.
Oral cancer must be differentiated from actinic keratosis, dermatologic manifestations of oral leukoplakia, erythroplasia, lichen planus and mucosal candidiasis.
Oral cancer differential diagnosis
Type of cancer | Subtype | ICD-O Code | Epidemiology | Etiology | Second primary tumors | Localization | Clinical features | Diagnostic procedures |
---|---|---|---|---|---|---|---|---|
Squamous cell carcinoma | Verrucous carcinoma | 8051/3 | Older males |
|
||||
Basaloid squamous cell carcinoma | 8083/3 | |||||||
Papillary squamous cell carcinoma | 8052/3 | |||||||
Spindle cell carcinoma | 8074/3 | |||||||
Acantholytic squamous cell carcinoma | 8075/3 | |||||||
Adenosquamous carcinoma | 8560/3 | |||||||
Carcinoma cuniculatum
(epithelioma cuniculatum) |
8051/3 | |||||||
Lymphoepithelial carcinoma | ||||||||
Epithelial precursor lesions | ||||||||
Proliferative verrucous leukoplakia and precancerous conditions | ||||||||
Papillomas | Squamous cell papilloma and
verruca vulgaris |
|||||||
Condyloma acuminatum | ||||||||
Papillomas and papillomatosis
in immunodeficiency |
||||||||
Focal epithelial hyperplasia | ||||||||
Granular cell tumour | ||||||||
Keratoacanthoma | ||||||||
Papillary hyperplasia | ||||||||
Median rhomboid glossitis | ||||||||
Median rhomboid glossitis | ||||||||
Salivary gland tumours | Acinic cell carcinoma | 8550/3 | ||||||
Mucoepidermoid carcinoma | 8430/3 | |||||||
Adenoid cystic carcinoma | 8200/3 | |||||||
Polymorphous low-grade
adenocarcinoma |
8525/3 | |||||||
Epithelial-myoepithelial
carcinoma |
8562/3 | |||||||
Clear cell carcinoma,
NOS |
8310/3 | |||||||
Basal cell
adenocarcinoma |
8147/3 | |||||||
Cystadenocarcinoma | 8450/3 | |||||||
Mucinous adenocarcinoma | 8480/3 | |||||||
Oncocytic carcinoma | 8290/3 | |||||||
Salivary duct carcinoma | 8500/3 | |||||||
Myoepithelial carcinoma | 8982/3 | |||||||
Carcinoma ex pleomorphic
adenoma |
8941/3 | |||||||
Salivary gland adenomas | Pleomorphic adenoma | 8940/0 | ||||||
Myoepithelioma | 8982/0 | |||||||
Basal cell adenoma | 8147/0 | |||||||
Canalicular adenoma | 8149/0 | |||||||
Duct papilloma | 8503/0 | |||||||
Cystadenoma | 8440/0 | |||||||
Kaposi sarcoma | ||||||||
Lymphangioma | ||||||||
Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
||||||||
Focal oral mucinosis | ||||||||
Congenital granular cell epulis | ||||||||
Haematolymphoid tumours | Non-Hodgkin lymphoma | Second most com-
mon cancer of the oral cavity. |
|
|
NHL of the lip presents with:
|
Biopsy shows:
| ||
Extramedullary plasmacytoma | 9734/3 | |||||||
Langerhans cell histiocytosis | 9751/1 | Associated with:
|
and
|
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |||
Hodgkin lymphoma | Strongly associated with Epstein- Barr Virus |
|
Most patients present with localized disease (stage I/II), with
|
|||||
Extramedullary myeloid
sarcoma |
9930/3 | History of acute myeloid leukaemia,
predominantly in the monocytic or myelomonocytic subtypes |
|
Isolated tumor-forming intraoral mass | Biopsy shows an Indian-file pattern of infiltration | |||
Follicular dendritic cell
sarcoma / tumour |
9758/3 |
|
History of underlying hya-line-vascular Castleman disease |
|
The patients usually
present with a painless mass |
Biopsy usually exhibits
borders and comprises:
| ||
Mucosal malignant melanoma | 8720/3 |
|
No known etiological factors associated with oral melanoma | 80% arise:
gingivae Others:
|
|
|